Subacute Thyroiditis in the SARS-CoV-2 Era
NCT06391515
COVID-19, Coronaviridae Infections
Modena, Italy
View Trial DetailsNCT Number: NCT00443833
Thyrotoxic periodic paralysis (TPP) is characterized by episodes of reversible hypokalemia and weakness in thyrotoxic patients. It is commonly found in males of Asian descent and is also seen in individuals having Native American or Hispanic ancestry. Therefore genetic etiology has been hypothesized. This study, we aim to find the susceptibility genes that associate with TPP. Both candidate genes approach and genome wide association study have been conducted.
Looking for future studies?
Notify Me15 year and older
Male
Observational
This study is a genetic association study. It included 50 cases of TPP patients and 80 cases of male, hyperthyroid patients who didn't have hypokalemia as a well characterized controls. After informed consent were obtained, genomic DNA from leukocyte were extracted. Pooled DNA were constructed and whole genome scan using 10K GeneChip microarray were genotyped on pooled genomic DNA.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
TPP
Exclusion criteria
Ramathibodi Hospital
Other
Genetic Analysis of Thai Patients With Thyrotoxic Periodic Paralysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06391515
COVID-19, Coronaviridae Infections
Modena, Italy
View Trial DetailsNCT05512715
Endocrine System Diseases, Hyperthyroidism
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT04485975
Endocrine System Diseases, Hyperthyroidism
View Trial DetailsNCT04304794
Contrast Media Adverse Reaction, Endocrine Gland Neoplasms
View Trial Details